Jangho

What Jangho does

Jangho Group Company Limited, founded in 1999 and headquartered in Beijing, is a publicly listed (Shanghai Stock Exchange: sh601886) engineering and construction group that designs, manufactures, and installs curtain wall systems and provides interior decoration services for commercial, residential, and landmark buildings worldwide. The company operates 7 production bases, 10+ overseas branches, and serves clients in more than 30 countries, with a flagship manufacturing facility in Guangzhou (Xintang) delivering 2 million square meters of annual curtain wall capacity. Its technical stack centers on BIM-based design, finite element analysis for structural deformation prediction, structural health monitoring systems, and MES-controlled intelligent manufacturing — capabilities that have earned it the only national-level enterprise technique center certification in the curtain wall industry and 17 Lu Ban awards. Major projects include the Jeddah Tower (world's tallest building) and Samrya Twins Tower in Qatar, with go-to-market executed through direct enterprise sales targeting developers and main contractors of landmark buildings.

Beyond its architectural decoration core, Jangho has pursued a deliberate diversification into healthcare services since 2015, anchored by the acquisition of Vision Eye Institute (Australia's largest eye care provider, founded 1959) and a controlling stake in Nanjing Zeming Hospital Management (China-based ophthalmology chain). The healthcare segment operates 43 ophthalmic medical institutions globally, providing cataract surgery, corneal transplantation, retinal surgery, laser therapy, and optometry services through brands such as Vision Eye Institute, Zeming Eye Hospital, and Vision Eye Group. The group also owns Sundart Holdings (interior decoration, separately listed on the Hong Kong Stock Exchange), Gangyuan Decoration, Gangyuan Curtain Wall, and Steve Leung Designers, forming a multi-brand portfolio across architectural construction and healthcare verticals.

Name

Jangho

Legal name

Jangho Group Company Limited

Website

http://en.jangho.com

Company type

Public

Founded year

1999

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Jangho Group is a Beijing-based publicly listed engineering and construction firm (SSE: sh601886) that designs, manufactures, and installs curtain wall systems for landmark buildings globally, and operates a chain of ophthalmology hospitals in Australia and China through its Vision Eye Institute and Zeming subsidiaries.

Ownership category

akta.pro rank

Product category

Architectural Façade and Curtain Wall Engineering

NAICS

Painting and Wall Covering Contractors (238320), Management of Companies and Enterprises (5511)

SIC

Metal Doors, Sash, Frames, Moldings & Trim (3442), Sheet Metal Work (3444)

akta.pro primary industry

Storefronts, Curtain Wall & Window Wall Systems (IMADAIAG)

akta.pro secondary industry

Residential Interior Fit-Out (Multi-Family & High-End) (IMAFANAE)

Keywords

• Curtain wall systems
• Building facade engineering
• Architectural decoration services
• Interior design solutions
• Ophthalmic healthcare services

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices12 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Curtain Wall Design, Manufacturing, and Installation: Project-based contracts for curtain wall systems including consulting, design development, intelligent manufacturing, installation, and maintenance services for commercial and residential buildings worldwide
2. Healthcare Services: Ophthalmic medical services including cataract surgery, corneal transplantation, retinal surgery, laser therapy, and optometric services through chain eye hospitals
3. Interior Decoration: Interior design and decoration services through Sundart Holdings and Gangyuan subsidiaries

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Jangho Group fundamentally designs, manufactures, and installs curtain wall systems for skyscrapers and landmark buildings globally through its Jangho Curtain Wall and Gangyuan Curtain Wall subsidiaries, and provides interior decoration services through Sundart Holdings, Gangyuan Decoration, and Steve Leung Designers. Through wholly-owned subsidiaries, the company also operates an ophthalmic healthcare business via Vision Eye Institute in Australia (15 hospitals, 9 ambulatory surgery centers, 6 laser centers) and Zeming Eye Hospitals in China, delivering cataract surgery, retinal surgery, laser therapy, and optometric services.

Product overview

Jangho Group operates two main business segments: Architectural Decoration (curtain wall systems, interior design, and construction) and Health Care (ophthalmology services). The architectural segment includes Jangho Curtain Wall (façade engineering), Sundart Holdings (interior decoration), Gangyuan Decoration, Gangyuan Curtain Wall, and SLD (interior design). The healthcare segment includes Vision Eye Institute (Australian-founded ophthalmic chain) and Zeming Eye Hospital (China-based ophthalmology chain).

Differentiator

Problem solved

Functional benefit

Brands

• Vision Eye Institute: International comprehensive ophthalmic chain medical group founded in Melbourne, Australia in 1959, providing eye care services. Australia's largest eye care provider and the first ophthalmic medical institution listed globally.
• Sundart Holdings Limited
• Gangyuan Decoration
• Steve Leung Designers Ltd.
• Zeming Eye Hospital
• Jangho Curtain Wall

Products and services

• Gangyuan Curtain Wall Systems
• Steve Leung Designers (SLD) Interior Design Services
• Jangho Curtain Wall Systems
• Sundart Holdings Interior Decoration Services
• Gangyuan Decoration Services
• Vision Eye Institute Ophthalmic Services
• Zeming Eye Hospital Chain Services

Quantifiable outcome

• Successfully installed first curtain wall unit at Jeddah Tower (450 kg, 1.5m × 5.3m) at 73.95m height
• +2 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Seven partnerships are on record, tiered minor and core.

• Jiangsu Ophthalmologist GroupminorStrategic or Co-development Partner · 13 June 2017Nanjing Zeming entered strategic cooperation with Jiangsu Ophthalmologist Group for ophthalmologist pool sharing, diagnostic technology consultation, remote consultation, operation management consulting, talent development, and medical resources sharing.
• Jingjiang Guangming Eye HospitalminorStrategic or Co-development Partner · 8 May 2017Nanjing Zeming acquired 60% share of Jingjiang Guangming Eye Hospital, a modern secondary eye hospital established in 2011 with advanced medical equipment and strong ophthalmic expertise in Central Jiangsu.
• Nanjing Zeming Hospital Management Co., Ltd.coreStrategic or Co-development Partner · 18 November 2016Jangho acquired 51% shares of Nanjing Zeming through transfer and capital increase. Zeming specializes in medical investment, consulting, and management of medical institutions with four specialized level II hospitals, one optical management company, and two medical equipment companies.
• Vision Eye Institute Limited (Australia)coreStrategic or Co-development Partner · 30 July 2015Jangho Group acquired and wholly owned Vision Eye Institute, Australia's largest eye care provider and the first listed chain eye hospital in the world. Vision operates 15 eye hospitals, 9 ambulatory surgery centers, and 6 laser eye surgery centers. The acquisition expanded Jangho's healthcare portfolio and enabled technology transfer to China operations.
• Royal Brisbane Hospital, Vision Australia, Macular Disease Foundation AustraliacoreTechnology or Integration · 1 January 2015Vision established strategic cooperation with over 20 prestigious institutions including Royal Brisbane Hospital, Vision Australia, Macular Disease Foundation Australia, Royal Australian and New Zealand College of Ophthalmologists, University of Sydney Medical School, Melbourne Medical School, and others for clinical education, training, and scientific research collaboration.
• Beijing University of Civil Engineering and ArchitectureminorStrategic or Co-development Partner · 18 October 2013Jangho Group signed agreement for jointly establishing talent training programs with Beijing University of Civil Engineering and Architecture.
• Northeastern UniversityminorStrategic or Co-development Partner · 18 July 2013Jangho Group and Northeastern University jointly established Jangho Architectural College for talent development and education.

Scale indicators10 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Yuanda China Holdings: Hong Kong-listed Chinese curtain wall and façade engineering contractor with a global project portfolio spanning supertall and complex commercial buildings; directly competes with Jangho Curtain Wall in the same customer segment (landmark developers) with similar unitized systems technology.
• Permasteelisa: Italy-headquartered global curtain wall contractor known for supertall and architecturally ambitious façades; competes head-to-head with Jangho on international mega-projects and shares the same technically demanding, design-led customer base.
• Gold Mantis Construction Decoration: Shenzhen-listed (002081.SZ) leading Chinese architectural decoration contractor combining interior fit-out, curtain wall, and design services; closest China-listed peer to Jangho's interior decoration and Sundart sub-brand, serving overlapping luxury hotel and commercial real estate customers.
• Far East Global Group: Hong Kong-listed curtain wall and façade contractor with international project delivery capabilities; competes with Jangho in the same commercial and high-rise curtain wall market with overlapping customers in Asia and the Middle East.
• Aier Eye Hospital Group: China's largest ophthalmology chain (300000.SZ), providing cataract, refractive, and optical services across hundreds of hospitals; directly comparable to Jangho's Vision/Zeming ophthalmology business and the dominant benchmark for the healthcare growth pillar.
• Huaxia Eye Hospital Group: Mid-sized Chinese ophthalmology hospital chain that, like Zeming, operates regional eye-care networks in China; comparable to Zeming in service mix (cataract, refractive, optometry) and geographic expansion strategy.

Broad incumbents

• Schüco: German global leader in aluminum building envelope systems including unitized curtain walls, windows, and façades; broader product portfolio but overlaps with Jangho in commercial and high-rise curtain wall supply and international landmark projects.
• YKK AP: Japanese global building products manufacturer with a large façade and curtain wall division; competes with Jangho in Asian supertall and commercial façade markets but operates as part of a much wider windows/doors portfolio.
• China State Construction Engineering (CSCEC): World's largest construction contractor and a major domestic façade/curtain wall buyer and competitor; not a pure-play curtain wall firm, but its in-house façade capabilities and developer relationships compete with Jangho on China's largest commercial projects.

Others

• China Resources Land: Large Hong Kong-listed Chinese property developer; not a competitor but a representative downstream customer whose commercial and mixed-use project pipeline drives demand for Jangho's curtain wall and interior decoration services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/jangho-group-co-ltd-

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Subsidiaries16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jangho